Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some functional changes in experimentally induced cardiac overload.

O Petkov

    Acta Physiologica Et Pharmacologica Bulgarica
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of 4-(4-bromophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride on acute gastric lesions, acid secretion in rats and on some hemodynamic parameters in cats.

    Methods and findings in experimental and clinical pharmacology·1999
    Same author

    Computer design and syntheses of antiulcer compounds. 1st communication: N-[3-[3-(1-piperidinomethyl)phenoxy]propyl]amines and benzamides.

    Arzneimittel-Forschung·1996
    Same author

    Synthesis, gastroprotective, antisecretory and anti-Helicobacter effect of N-[3-(3-(1-piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex (MX1)-MX1.

    The Journal of pharmacy and pharmacology·1996
    Same author

    Involvement of Ca2+ and alpha 1-adrenoceptors in endothelin-1 effects on the tone and electrically evoked contractions of rabbit ear central artery.

    Methods and findings in experimental and clinical pharmacology·1995
    Same author

    Interactions between the effects of endothelin-1, clonidine and yohimbine on electrically-induced contractions in rat vas deferens.

    General pharmacology·1992
    Same author

    Changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and M-cholinergic systems in experimental isoprenaline myocardial hypertrophy.

    Acta physiologica et pharmacologica Bulgarica·1991

    This study investigates myocardial hypertrophy (MH) using isoprenaline in rats and thyreotom in rabbits. Adrenergic mechanisms play a key role, with some compounds showing protective effects against cardiac damage.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Pathophysiology

    Background:

    • Cardiac overloading can induce acute and chronic hemodynamic stress.
    • Neurotransmitter systems are implicated in the development of myocardial hypertrophy (MH).
    • Understanding the pathogenesis of MH is crucial for developing effective treatments.

    Purpose of the Study:

    • To elucidate the mechanisms of hemodynamic stress in cardiac overloading.
    • To investigate the role of neurotransmitter systems in the genesis of MH.
    • To evaluate the effects of various pharmacological agents on experimentally induced MH.

    Main Methods:

    • Myocardial hypertrophy (MH) was modeled in rats using isoprenaline (ISO) and in rabbits using thyreotom.
    • Combinations of ISO and thyreotom with oxprenolol, atropine, phentolamine (Phent.), and amino-oxyacetic acid (AOAA) were administered.

    Related Experiment Videos

  • Electrocardiogram (ECG) studies were performed to assess cardiac function and morphology.
  • Main Results:

    • Significant MH was observed in rats treated with ISO and in rabbits treated with thyreotom, the latter accompanied by hypertension.
    • Rats treated with ISO + Phent. exhibited considerable functional and morphological damage, including subendocardial fibrous proliferations.
    • Oxprenolol and AOAA demonstrated a protective effect in rabbits with thyrotoxic disturbances.

    Conclusions:

    • Adrenergic mechanisms play an essential role in the pathogenesis of MH.
    • Pharmacological interventions can modulate the development of MH and associated cardiac damage.
    • Further research into neurotransmitter systems and adrenergic pathways is warranted for MH treatment.